Integra LifeSciences today announced it launched its MicroMatrix Flex dual-syringe system for urinary bladder matrix (UBM) access.
The Princeton, N.J.-based company designed MicroMatrix Flex to enable the convenient mixing and precise delivery of MicroMatrix paste to provide more convenient access to hard-to-reach spaces in wound management.
“MicroMatrix Flex has allowed me to expand how I use UBM technology in complex wound reconstruction procedures,” said Dr. Aaron Moore, an acute care surgeon at Mercy Health St. Vincent Medical Center. “In addition to the benefits of UBM technology, the flexible delivery tip addresses the need to access hard-to-reach geometries in complex wounds.”
MicroMatrix Flex is intended to manage wounds, including partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds, trauma wounds and draining wounds.
The device has a flexible dispensing tip to address tunneled, undermined and irregular wounds. The mixing system creates a paste with a flowable consistency that provides thorough contact with all areas of a wound.
“Our UBM technology supports complex wound management, and MicroMatrix Flex allows access to otherwise ‘hidden’ areas of a wound. We developed this innovation through years of research and collaboration. It further expands our comprehensive regenerative medicine offerings across Integra,” Thomas Gilbert, VP of research and development and process technology in Integra’s tissue technologies business, said in a news release.
